US equities
|
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
NVDA
$125.53
▼-14.01%
ANT
$88.91
▼-8.50%
MU
$594.51
▼-13.89%
AMD
$424.39
▼-13.25%
AAPL
$342.56
▼-1.90%
MSFT
$484.52
▼-2.77%
AMZN
$246.82
▼-4.10%
AVGO
$304.41
▼-12.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about CAR T/cell Therapy
Recent news which mentions CAR T/cell Therapy
Gilead Sciences: U.S. Military Veteran Battles Lymphoma With Car T-Cell Therapy: Marcus' Story
December 08, 2022
Tags
Lymphoma
Health & Healthcare
NYSE:GILD
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Overcoming Blood Cancer With CAR T-cell Therapy: Eleonora's Journey
September 07, 2022
Tags
blood cancer
NYSE:GILD
Health & Healthcare
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Mom Celebrates Sons' Milestones: Julie's CAR T-cell Therapy Journey
April 20, 2022
Tags
Lymphoma
Gilead
CAR T/cell Therapy
From
3BL Media: Corporate Social Responsibility, Energy and Health News